
|Videos|March 12, 2022
Augmenting corneal thickness with FDA-approved hypotonic riboflavin
Author(s)Alex Delaney-Gesing, Senior Editor
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin during SECO 2022.
Advertisement
Daniel Fuller, OD, FAAO Dipl., FSLS, discusses his SECO 2022 presentation "Augmenting corneal thickness in thin keratoconus corneas during corneal cross-linking via FDA-approved hypotonic riboflavin," with Optometry Times®' Alex Delaney-Gesing.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
Takeaways from this week in optometry: December 1 - December 5
2
Phase 1 trial findings confirm safety and tolerability of Huons’ dry eye therapy
3
The mechanics of presbyopia: From muscle movement to functional vision
4
Majority of US patients with dry eye experience symptoms weekly, survey finds
5















































.png)


